1
|
73 y, male
|
Diabetes, Chronic lung disease, Myocardial infarction
|
CABGx3 (LIMA-LAD)
|
11
|
3.5
|
2
|
67 y, male
|
Diabetes, Chronic lung disease, BMI 30 to 40 kg/m2, Peripheral vascular disease
|
CABGx1 LIMA-LAD AVR
|
18
|
8.5
|
3
|
63 y, male
|
Chronic lung disease, Peripheral vascular disease, Myocardial infarction
|
CABGx3 (LIMA and RITA)
|
8
|
2.3
|
4
|
78 y, female
|
Diabetes, Renal failure, BMI 30 to 40 kg/m2, Peripheral vascular disease
|
CABGx1 (LIMA-LAD) and AVR
|
23
|
12.5
|
5
|
65 y, female
|
Diabetes, Renal failure, BMI 30 to 40 kg/m2, Peripheral vascular disease, Myocardial infarction, Cardiogenic shock
|
CABGx1 (LIMA-LAD) and MVR
|
30
|
16.2
|
6
|
62 y, male
|
Diabetes, Peripheral vascular disease, Myocardial infarction
|
CABGx3 (LIMA and RITA)
|
9
|
2.7
|
7
|
72 y, female
|
Diabetes, Peripheral vascular disease, Myocardial infarction
|
CABGx3 (LIMA-LAD)
|
13
|
4.5
|
8
|
62 y, female
|
Diabetes, BMI 30 to 40 kg/m2, Peripheral vascular disease, Myocardial infarction
|
CABGx3 (LIMA and RITA)
|
15
|
6.0
|
9
|
65 y, female
|
Diabetes, Peripheral vascular disease, Myocardial infarction
|
CABGx3 (LIMA and RITA)
|
12
|
4.0
|
10
|
55 y, male
|
Diabetes, BMI 30 to 40 kg/m2, Peripheral vascular disease, Myocardial infarction
|
CABGx3 (LIMA and RITA)
|
12
|
4.0
|